Suven Pharmaceuticals Ltd

SUVENPHAR
Health CarePharmaceuticals
SmallcapWith a market cap of ₹13,288 cr, stock is ranked 279
Moderate RiskStock is 2.09x as volatile as Nifty
521.600.40 (-0.08%)

Price Chart

High
Low
Returns
1D
1W
1M
1Y
5Y
Max
SIP
Loading...
1D
1W
1M
1Y
5Y
Max
SIP
Investment Checklist
BasicPro
Go pro! Unlock deeper insights
Health CarePharmaceuticals
SmallcapWith a market cap of ₹13,288 cr, stock is ranked 279
Moderate RiskStock is 2.09x as volatile as Nifty

Key Metrics

PE RatioPE Ratio
29.28
PB RatioPB Ratio
11.25
Dividend YieldDiv. Yield
0.96%
Sector PESector PE
33.53
Sector PBSector PB
4.83
Sector Div YldSctr Div Yld
0.83%

Forecast & RatingsDetailed Forecast 

83%

Analysts have suggested that investors can buy this stock

Price

Price Upside

Pro Only

Earnings

Earnings Growth

Pro Only

Revenue

Rev. Growth

Pro Only

See Detailed Forecast

Company Profile

Suven Pharmaceuticals is engaged in Contract Research and Manufacturing Services (CRAMS), Drug Discovery & Development Support Services (DDDSS), Drug Discovery & Research/Clinical Pipeline, and Formulation Development

Investor PresentationView older 

May 9, 2022

PDF
View Older Presentations

Get more out of Tickertape, Go Pro!

Customise key metrics, see detailed forecasts, download stock data and more

See Plans

Financial TrendFinancial statements 

20192020202120220.380.901.081.450.110.320.360.45
Revenue
Profit
All values in ₹ Thousand cr.
See financial statements

Holdings TrendDetailed holdings 

Total Promoter Holding
Increasing promoter holding is considered good and reflects management’s positive view about the future outlook

In last 6 months, promoter holding in the company has almost stayed constant

Low Pledged Promoter Holding
Lower pledged promoter holdings is considered better

Pledged promoter holdings is insignificant

Mutual Fund Holding
Increasing Mutual Fund holdings are generally considered good, as it reflects that fund managers are becoming more bullish about the stock

In last 3 months, mutual fund holding of the company has almost stayed constant

See detailed holdings

Recent EventsAll events 

Related Party Transaction 
Announced OnMay 21, 2022

Suven Pharmaceuticals Limited has informed the Exchange about related party transaction for the period ended March 2022 | Download

Suven Pharmaceuticals Limited has informed the Exchange about related party transaction for the period ended March 2022 | Download

Transcript of Analysts/Institutional Investor Meet/Con. Call 
Announced OnMay 13, 2022

Suven Pharmaceuticals Limited has informed the Exchange about Transcript of Analysts/Institutional Investor Meet/Con. Call | Download

Suven Pharmaceuticals Limited has informed the Exchange about Transcript of Analysts/Institutional Investor Meet/Con. Call | Download

Cash Dividend 
Ex. DateMay 13, 2022

Interim 2 • Div/Share: ₹ 1

See all events